Related Articles
Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1 Corrigendum in /10.3892/etm.2023.12021
Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling
Astragaloside IV downregulates the expression of MDR1 in Bel‑7402/FU human hepatic cancer cells by inhibiting the JNK/c‑Jun/AP‑1 signaling pathway